Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6:598

Article  PubMed  PubMed Central  Google Scholar 

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K (2020) Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol 18:117–124

Article  CAS  PubMed  Google Scholar 

Chawla A, Chawla R, Jaggi S (2016) Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 20:546–551

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rübsam A, Parikh S, Fort PE (2018) Role of inflammation in diabetic retinopathy. Int J Mol Sci 19:942

Article  PubMed  PubMed Central  Google Scholar 

Dascalu AM, Serban D, Tanasescu D, Vancea G, Cristea BM et al (2023) The value of white cell inflammatory biomarkers as potential predictors for diabetic retinopathy in type 2 diabetes mellitus (T2DM). Biomedicines 11:2106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Golestani A, Rahimi A, Moezi Bady SA, Azdaki N, Sajjadi SM (2024) Src homology 2-B adapter protein 3 C784 T and methylenetetrahydrofolate reductase C677 T polymorphisms and inflammation markers in ST-segment elevation myocardial infarction patients. Angiology 75:281–287

Article  CAS  PubMed  Google Scholar 

Luo W-J, Zhang W-F (2019) The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a meta-analysis and systematic review. Int J Ophthalmol 12:312

PubMed  PubMed Central  Google Scholar 

Khalighi K, Cheng G, Mirabbasi S, Khalighi B, Wu Y, Fan W (2018) Opposite impact of methylene tetrahydrofolate reductase C677T and Methylene tetrahydrofolate reductase A1298C gene polymorphisms on systemic inflammation. J Clin Lab Anals 32:e22401

Article  Google Scholar 

Wang Z, Kong L, Luo G, Zhang H, Sun F et al (2022) Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism. Thromb J 20:68

Article  PubMed  PubMed Central  Google Scholar 

Pruthi RK, Kluge ML, Ashrani AA (2016) Coagulation disorders. Molecular pathology in clinical practice: 203–223.

Perez-Pujol S, Aras O, Escolar G (2012) Factor V Leiden and inflammation. Thrombosis 2012:594986

Article  PubMed  PubMed Central  Google Scholar 

Fekih-Mrissa N, Mrad M, Ibrahim H, Akremi I, Sayeh A et al (2017) Methylenetetrahydrofolate reductase (MTHFR)(C677T and A1298C) polymorphisms and vascular complications in patients with type 2 diabetes. Can J Diabetes 41:366–371

Article  PubMed  Google Scholar 

Ganguly P, Alam SF (2015) Role of homocysteine in the development of cardiovascular disease. Nutr J 14:1–10

Article  Google Scholar 

Hammons AL, Summers CM, Woodside JV, McNulty H, Strain J et al (2009) Folate/homocysteine phenotypes and MTHFR 677C> T genotypes are associated with serum levels of monocyte chemoattractant protein-1. Clin Immunol 133:132–137

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahimi A, Moridi N, Golestani A, Anani-Sarab G, Salmani F et al (2024) Factor V Leiden, MTHFR, and FXIIIVal34Leu gene polymorphisms and their association with clinical features and risk of diabetic retinopathy in patients with type 2 diabetes. Caspian J Intern Med 15:101

PubMed  PubMed Central  Google Scholar 

Mohamed S (2017) Relationship between diabetic retinopathy and methylenetetrahydrofolate reductase gene polymorphism. Egypt J Hosp Med 67:628–634

Article  Google Scholar 

Collins A, Ke X (2012) Primer1: primer design web service for tetra-primer ARMS-PCR. Open Bioinform J 6:55–58

Article  Google Scholar 

Enjeti AK, Lincz LF, Scorgie FE, Seldon M (2010) Circulating microparticles are elevated in carriers of factor V Leiden. Thromb Res 126:250–253

Article  CAS  PubMed  Google Scholar 

Perez-Pujol S, Aras O, Escolar G (2012) Factor V Leiden and inflammation. Thrombosis 2012:1–10

Article  Google Scholar 

Ciray H, Aksoy A, Ulu N, Cizmecioglu A, Gaipov A, Solak Y (2015) Nephropathy, but not angiographically proven retinopathy, is associated with neutrophil to lymphocyte ratio in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 123:267–271

Article  CAS  PubMed  Google Scholar 

Ulu SM, Dogan M, Ahsen A, Altug A, Demir K et al (2013) Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther 15:942–947

Article  CAS  PubMed  Google Scholar 

Wang R-t, Zhang J-r, Li Y, Liu T, Yu K-j (2015) Neutrophil–lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes. J Diabetes Complicat 29:245–249

Article  Google Scholar 

Moursy EY, Megallaa MH, Mouftah RF, Ahmed SM (2015) Relationship between neutrophil lymphocyte ratio and microvascular complications in Egyptian patients with type 2 diabetes. Am J Intern Med 3:250–255

Google Scholar 

Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K et al (2010) Usefulness of neutrophil to lymphocyte ratio in predicting short-and long-term mortality after non–ST-elevation myocardial infarction. Am J Cardio 106:470–476

Article  Google Scholar 

Sala A, Folco G (2001) Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation? Biochem Biophys Res Commun 283:1003–1006

Article  CAS  PubMed  Google Scholar 

Huang X, Yang S, Zhao Q, Chen X, Pan J, et al. (2022) Predictive value of non-high-density lipoprotein cholesterol and neutrophil-lymphocyte ratio for coronary artery vulnerable plaques in type 2 diabetes mellitus. Front Cardiovasc Med: 1606.

Azab B, Daoud J, Naeem FB, Nasr R, Ross J et al (2012) Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail 34:571–576

Article  CAS  PubMed  Google Scholar 

Jaaban M, Zetoune AB, Hesenow S, Hessenow R (2021) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon 7:e07564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H (2019) Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras 65:38–42

Article  PubMed  Google Scholar 

Liu N, Sheng J, Pan T, Wang Y (2019) Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with lower extremity vascular lesions in Chinese patients with type 2 diabetes. Clin Lab 65

Mineoka Y, Ishii M, Hashimoto Y, Yamashita A, Nakamura N, Fukui M (2019) Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes. Endoc J 66:905–913

Article  CAS  Google Scholar 

Mohamed AF, Mahmoud Nassar M, Maher RSM, Shaker O, Mohamed YA (2024) Assessment of hematological biomarkers, including neutrophil-lymphocyte and platelet-lymphocyte ratios, in diabetic nephropathy for patients with type 2 diabetes. Med J Cairo Univ 92:559

Article  Google Scholar 

Zhu Y, Cai Q, Li P, Zhou Y, Xu M, Song Y (2022) The relationship between peripheral blood inflammatory markers and diabetic macular edema in patients with severe diabetic retinopathy. Ann Palliat Med 11:98492–98992

Article  Google Scholar 

Dascalu AM, Georgescu A, Costea AC, Tribus L, El Youssoufi A et al (2023) Association between neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with diabetic retinopathy in type 2 diabetic patients. Cureus. https://doi.org/10.7759/cureus.48581

Article  PubMed  PubMed Central  Google Scholar 

Chatterjee M, Geisler T (2016) Inflammatory contribution of platelets revisited: new players in the arena of inflammation. Seminars in thrombosis and hemostasis, 205–214 (Abstract).

Jenne C, Urrutia R, Kubes P (2013) Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol 35:254–261

Article  CAS  PubMed  Google Scholar 

Rena G, Hardie DG, Pearson ER (2017) The mechanisms of action of metformin. Diabetologia 60:1577–1585

Article  CAS  PubMed  PubMed Central  Google Scholar